Heart

Systolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Wed, 13 Jul 2022 12:37:01 +0000

Summary

Systolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Systolic Heart Failure pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Systolic Heart Failure, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s proprietary databas...

$2,000.00

Chronic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Tue, 12 Jul 2022 13:59:20 +0000

Summary

Chronic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Chronic Heart Failure pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chronic Heart Failure, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases,...

$2,000.00

Global Transcatheter Heart Valve Replacement Market

Fri, 03 Jun 2022 10:32:26 +0000

ResearchCubes Global Transcatheter Heart Valve Replacement Market Pulse Report is a great resource to understand the market size, geographical segmentation, products in development, clinical trials, competitive landscape in a fresh new format designed for exploratory research. The report has been conceptualizeed by industry leaders keeping in mind the critical & timely requirement of business information of medical devices business leaders. The report provides a 40,000 feet height and 360 degree view of the medical device segment at an afforable price point. The attempt has been to provide top level data points with the option of access to granualr data if required for an additional cost. • What is the current Global Transcatheter Heart Valve Replacement Market size and future potential? • What is the geographical segmentation of the Global Transcatheter Heart Valve Replacement Market? • What are the emerging pipeline products available in the Global Transcatheter Heart Valve Replacement Market? • What are the various products currently under development/pip...

$2,000.00

Global Transcatheter Heart Valve Replacement Market

Fri, 03 Jun 2022 10:32:26 +0000

ResearchCubes Transcatheter Heart Valve Replacement Market Pulse Report is a great resource to understand the market size, geographical segmentation, products in development, clinical trials, competitive landscape in a fresh new format designed for exploratory research. The report has been conceptualizeed by industry leaders keeping in mind the critical & timely requirement of business information of medical devices business leaders. The report provides a 40,000 feet height and 360 degree view of the medical device segment at an afforable price point. The attempt has been to provide top level data points with the option of access to granualr data if required for an additional cost. • What is the current Transcatheter Heart Valve Replacement Treatment Devices Market size and future potential? • What is the geographical segmentation of the Transcatheter Heart Valve Replacement Treatment Devices Market? • What are the emerging pipeline products available in the Transcatheter Heart Valve Replacement Treatment Devices Market? • What are the various products curre...

$2,000.00

Global Heart Valve Replacement Market

Fri, 03 Jun 2022 10:32:26 +0000

ResearchCubes Heart Valve Replacement Market Pulse Report is a great resource to understand the market size, geographical segmentation, products in development, clinical trials, competitive landscape in a fresh new format designed for exploratory research. The report has been conceptualizeed by industry leaders keeping in mind the critical & timely requirement of business information of medical devices business leaders. The report provides a 40,000 feet height and 360 degree view of the medical device segment at an afforable price point. The attempt has been to provide top level data points with the option of access to granualr data if required for an additional cost. • What is the current Heart Valve Replacement Treatment Devices Market size and future potential? • What is the geographical segmentation of the Heart Valve Replacement Treatment Devices Market? • What are the emerging pipeline products available in the Heart Valve Replacement Treatment Devices Market? • What are the various products currently under development/pipeline in the Heart Valve Repla...

$2,000.00

Global Heart Valve Repair Market

Fri, 03 Jun 2022 10:32:26 +0000

ResearchCubes Heart Valve Repair Market Pulse Report is a great resource to understand the market size, geographical segmentation, products in development, clinical trials, competitive landscape in a fresh new format designed for exploratory research. The report has been conceptualizeed by industry leaders keeping in mind the critical & timely requirement of business information of medical devices business leaders. The report provides a 40,000 feet height and 360 degree view of the medical device segment at an afforable price point. The attempt has been to provide top level data points with the option of access to granualr data if required for an additional cost. • What is the current Heart Valve Repair Treatment Devices Market size and future potential? • What is the geographical segmentation of the Heart Valve Repair Treatment Devices Market? • What are the emerging pipeline products available in the Heart Valve Repair Treatment Devices Market? • What are the various products currently under development/pipeline in the Heart Valve Repair Treatment Devices ...

$2,000.00

Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 08 Apr 2022 11:35:28 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Congestive Heart Failure (Cardiovascular) pipeline landscape.

Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver or abdomen, swollen feet and ankles and weight gain. There are two types of heart failure including systolic heart failure (left ventricle loses its ability to contract normally) and diastolic heart failure (left ventricle loses its ability to relax normally). The predisposing factors include high blood pressure, diabetes, sleep apnea, alcohol use and irregular heartbeats. Treatment includes surgery, vasodilator, beta blockers and diuretics.

Report Highlights

Global Markets Direct's Pharma...

$2,500.00

Global Artificial Heart Valve Market Research Report 2021-2025

Wed, 08 Sep 2021 15:45:00 +0000

An artificial heart valve is a device implanted into the heart of a patient to replace a dysfunctional native heart valve (valvular heart disease). In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Artificial Heart Valve Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Artificial Heart Valve market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025. The report firstly introduced the Artificial Heart Valve basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the wo...

$3,200.00

Global Artificial Heart Market Research Report 2021-2025

Wed, 08 Sep 2021 15:45:00 +0000

An artificial heart is a device that replaces the heart. Artificial hearts are typically used to bridge the time to heart transplantation, or to permanently replace the heart in case heart transplantation is impossible. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Artificial Heart Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Artificial Heart market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025. The report firstly introduced the Artificial Heart basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost struct...

$3,200.00

Global Heart Blocks Treatment Devices Market Research Report 2021-2025

Wed, 08 Sep 2021 14:53:50 +0000

Heart block also termed as atrioventricular (AV) block refers to a condition, in which the electric signals that regulate the heartbeat are moderately or absolutely blocked from reaching the ventricles. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Heart Blocks Treatment Devices Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Heart Blocks Treatment Devices market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025. The report firstly introduced the Heart Blocks Treatment Devices basics: definitions, classifications, applications and market overview; product specifications; manufacturi...

$3,200.00

Chronic Heart Failure - Global Clinical Trials Review, H2, 2021

Fri, 03 Sep 2021 16:07:52 +0000

Summary

GlobalData's clinical trial report, “Chronic Heart Failure - Global Clinical Trials Review, H2, 2021" provides an overview of Chronic Heart Failure Clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to g...

$2,500.00

Total Artificial Heart Market Insights, Competitive Landscape and Market Forecast–2025

Fri, 05 Feb 2021 15:36:57 +0000

DelveInsight’s ‘Total Artificial Heart -Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Total Artificial Heart and the historical and forecasted Total Artificial Heart market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan. The Total Artificial Heart market report provides an overview of Total Artificial Heart , reasons to get Total Artificial Heart as well as its advantages and limitations. Additionally, the report provides insight on the Total Artificial Heart market share of the individual Total Artificial Heart devices, current and forecasted Total Artificial Heart market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market. Total Artificial Heart Overview Artificial hearts are used to assist people with utter heart failure to live normal lives beyond their life expectancy time line, or to assist pa...

$4,750.00

Congenital Heart Disease - Global Clinical Trials Review, H2, 2020

Tue, 15 Dec 2020 12:29:33 +0000

Summary

GlobalData's clinical trial report, “Congenital Heart Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Congenital Heart Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Congenital Heart Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strate...

$2,500.00

Acute Heart Failure Global Clinical Trials Review, H2, 2018

Fri, 07 Dec 2018 15:32:55 +0000

Summary

GlobalData's clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H2, 2018" provides an overview of Acute Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain...

$2,500.00

Systolic Heart Failure Global Clinical Trials Review, H2, 2018

Wed, 17 Oct 2018 16:06:20 +0000

Summary

GlobalData's clinical trial report, “Systolic Heart Failure Global Clinical Trials Review, H2, 2018" provides an overview of Systolic Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Systolic Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategie...

$2,500.00

Heart Transplant Rejection - Pipeline Review, H2 2017

Thu, 18 Jan 2018 15:45:29 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heart Transplant Rejection - Pipeline Review, H2 2017, provides an overview of the Heart Transplant Rejection (Immunology) pipeline landscape.

Heart transplantation is the therapy used in various heart diseases. Heart transplant replaces an injured or diseased heart with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplant, the immune system may consider the transplanted heart as foreign and may work against it. Patients may hence develop complications and eventually reject the new organ. Immunosuppressive drugs are administered simultaneously which prevent the body from either identifying or attacking the foreign organ via various immune responses thus blocking organ rejection and facilitating a successful transplant.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Heart Transplant Rejection - Pipeline Review...

$2,000.00

US Market Report for Tissue Heart Valves 2018 - MedCore

Wed, 17 Jan 2018 11:28:21 +0000

Tissue valves, which are also known as bioprosthetic valves, are harvested from either human donors or animal tissue. Human tissue valves can either be obtained from donor cadavers in allograft procedures, or from one’s own body in an autograft procedure. Allograft valves may be acquired from deceased family members or anonymous donors. Autograft valves may be obtained through a Ross procedure, whereby part of the pulmonary valve is grafted and harvested into the aortic position. Whether autograft or allograft, human donor valves involve complicated extraction and insertion procedures. Human tissue valves are in limited supply and typically do not function drastically better than xenograft valves. ...

$3,995.00

US Market Report for Mechanical Heart Valves 2018 - MedCore

Wed, 17 Jan 2018 11:28:21 +0000

Mechanical heart valves are prosthetic devices designed to replicate the function of the natural valves of the human heart. Mechanical valves are designed to outlast the patient and some have been stress-tested to last several hundred years. Although mechanical valves are long-lasting and generally only require one surgery for installation, they contribute to an increased risk of blood clot formation. As a result, mechanical valve recipients often take anti-coagulant (blood thinning) drugs such as warfarin for the rest of their lives, which makes the patient more prone to bleeding. Given their durability, mechanical valves are primarily indicated for younger patients and for mitral valve replacement due to its high-pressure gradient. The primary advantage of mechanical over tissue valves is that once a mechanical valve is implanted, they never wear down and rarely need to be replaced. Mechanical valves are made from either pyrolytic carbon or titanium that has been coated with pyrolytic carbon. Pyrolytic carbon is similar to graphite and is used for many biomedical applications. They...

$2,995.00

Chronic Heart Failure - Market Insights, Epidemiology and Market Forecast-2023

Tue, 25 Apr 2017 20:08:12 +0000

Note*: This report requires 7-10 business days to complete. DelveInsight’s Chronic Heart Failure - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chronic Heart Failure forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chronic Heart Failure till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Chronic Heart Failure market. • Identifying patient populations in the global “Chronic Heart Failuremarket to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the best opportunities for Chronic Heart Failure therapeutics in each of...

$4,950.00

Heart Transplant Rejection - Pipeline Review, H2 2016

Fri, 07 Apr 2017 13:51:23 +0000

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Heart Transplant Rejection Overview 5
Therapeutics Development 6
Pipeline Products for Heart Transplant Rejection - Overview 6
Pipeline Products for Heart Transplant Rejection - Comparative Analysis 7
Heart Transplant Rejection - Therapeutics under Development by Companies 8
Heart Transplant Rejection - Pipeline Products Glance 9
Early Stage Products 9
Heart Transplant Rejection - Products under Development by Companies 10
Heart Transplant Rejection - Companies Involved in Therapeutics Development 11
Astellas Pharma Inc 11
Nekonal Sarl 12
Noxxon Pharma AG 13
Pelican Therapeutics Inc 14
Heart Transplant Rejection - Therapeutics Assessment 15
Assessment by Monotherapy Products 15
Assessment by Target 16
Assessment by Mechanism of Action 18
Assessment by Route of Administration 20
Assessment by Molecule Type 22
Drug Profiles 23
AS-2521780 - Drug Profile 23
Product Descrip...

$2,000.00

Acute Heart Failure Global Clinical Trials Review, H1, 2017

Fri, 07 Apr 2017 11:35:17 +0000

Summary

GlobalData's clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H1, 2017" provides an overview of Acute Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain...

$2,500.00

Diastolic Heart Failure Global Clinical Trials Review, H2, 2016

Wed, 11 Jan 2017 12:42:31 +0000

Summary

GlobalData's clinical trial report, “Diastolic Heart Failure Global Clinical Trials Review, H2, 2016" provides an overview of Diastolic Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Diastolic Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strate...

$2,500.00

Hypertrophic Cardiomyopathy - Pipeline Review, H2 2016

Fri, 09 Dec 2016 10:18:51 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertrophic Cardiomyopathy - Pipeline Review, H2 2016, provides an overview of the Hypertrophic Cardiomyopathy (Cardiovascular) pipeline landscape.

Hypertrophic cardiomyopathy (HCM) is a disease in which the heart muscle (myocardium) becomes abnormally thick (hypertrophied). The thickened heart muscles make it harder for the heart to pump blood. Symptoms include chest pain, especially during exercise, sensation of rapid, fluttering or pounding heartbeats and heart murmur. Hypertrophic cardiomyopathy usually is inherited. Treatment includes beta blockers, calcium channel blockers and blood thinners.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Hypertrophic Cardiomyopathy - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Hypertrophic Cardiomyopathy (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of actio...

$2,000.00

Ventricular Tachycardia - Pipeline Review, H2 2016

Fri, 09 Dec 2016 10:18:51 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ventricular Tachycardia - Pipeline Review, H2 2016, provides an overview of the Ventricular Tachycardia (Cardiovascular) pipeline landscape.

Ventricular tachycardia is a very fast heart rhythm that begins in the ventricles. Symptoms of ventricular tachycardia include dizziness, fainting, fatigue, chest pain and shortness of breath. Causes include cardiomyopathy, ischemic heart disease and heart failure. Risk factors include age, family history and medical history. Treatment includes antiarrhythmic medication.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Ventricular Tachycardia - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Ventricular Tachycardia (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacol...

$2,000.00

PharmaPoint: Heart Failure - Global Drug Forecast and Market Analysis to 2025

Fri, 16 Sep 2016 20:41:29 +0000

Summary

GlobalData estimates sales of Heart Failure (HF) therapeutics to be approximately $3.2B across the 7MM in 2015, encompassing the US, 5EU, and Japan. The HF market will grow at a strong CAGR of 13.5% over the forecast period, reaching sales of $11.5B by 2025. The 7MM chronic HF market size in 2015 was $3.1B, and is expected to increase to $10.1B by 2025 at a CAGR of 12.7%. The US was the largest market for chronic HF therapies, contributing 61.2% of total sales in the base year. GlobalData expects uptake of Novartis’ Entresto to be the strongest driver of the chronic HF and total HF markets in the 7MM, reaching peak sales of $5.9B in 2022. The acute HF market is expected to increase from just $188.1M in 2015 to $1.5B in 2025, at a CAGR of 23.0%. Japan dominated the acute HF market in the base year, 2015, accounting for 86.0% of market share. However, with the launch of several acute HF add-on therapies in the forecast period, the US will take over as the acute HF market leader, contributing 68.7% of sales to the acute HF market by 2025.

Highlights
...

$10,995.00